AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

Abivax has reported positive topline results from Part 2 of [...]

Abivax will present nine scientific abstracts on obefazimod at Digestive [...]

Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

Abivax has presented new preclinical and clinical data for obefazimod [...]

Long-term VIVID-2 data show more than 90% of patients with [...]

Amorphical has announced positive final long-term results from its Phase [...]

The Scottish Medicines Consortium (SMC) has accepted guselkumab for the [...]

Immunai has signed an agreement worth up to $85 million [...]